blood samples for detecting actionable oncogenic mutations in lung cancer
Published 8 years ago • 206 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
2:55
limitations of genetic testing for actionable mutations in lung cancer
-
1:22
the identification of actionable mutations in lung cancer via ctdna
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
1:02
blood tests for identifying and monitoring alk-positive non-small cell lung cancer
-
15:19
impact of liquid biopsy testing on identifying actionable mutations
-
1:16
dr. halmos on detecting actionable mutations in patients with lung cancer
-
2:09
the advances and limitations of genetic testing for actionable mutations
-
1:37
ngs for the detection of mutations in nsclc
-
5:59
diagnostic testing for genetic mutations in lung cancer
-
1:57
cascade-lung: validation of a blood-based assay that evaluates cfdna patterns to detect lung cancer
-
1:59
limitations in genetic testing for lung cancer
-
42:10
detection of mutations from liquid biopsies - applications in cancer diagnostics
-
8:29
liquid vs. tissue biopsies to detect t790m mutations
-
38:04
blood-based detection: egfr/ kras mutations for nsclc patients using multiplexed droplet digital pcr
-
2:58
integrating plasma testing for actionable mutations in mnsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
2:32
genomic testing for lung cancer in the uk
-
16:35
heterogeneity of nsclc and precipitating oncogenic driver mutations
-
1:13
targeting oncogenes in nsclc